Skip Ribbon Commands
Skip to main content
Menu

Pharma RFP/Invitation Notices

Terms and Conditions: 

  1. All RFP proposals must be submitted through the Ariba sourcing tool.
  2. Your company must be registered in Singapore to participate in ALPS events.
  3. For all events, the Supply Head requirement for participation is EPU/DAP/32.
  4. Each Company must participate at all sourcing events through or using the same Ariba account. 

You can gain direct access into events by following the steps outlined below:
  • Click on the respective link found in the column “Respond to Posting”. You will be directed to the next page
  • Click on the “Respond to Posting” button found on the page
  • Log in to Ariba by entering your Ariba ID and password
  • You will gain access into the event for proposal submission
  • Submit your proposal in the Ariba sourcing tool before the closing date and time stated in the RFP notice below ​ 

Contact Persons:


Lim Liu Gin (Tel: 6377 8993)

Neo Li Zhu (Tel: 6377 8432)


Purchasing Programme

Evaluation Criteria

Evaluation Criteria (Unregistered Drugs)

RFP Results (Updated on 26 January 2023)

Estimated Annual Quantities


RFP/Invitation Notices


  
Event Description
  
  
  
  
  
  
Remarks
GPOR 73122

​Item 1 - Unregistered Drugs

GPOR 7312220/01/202310/2/2023 12:00 PMhttp://discovery.ariba.com/rfx/15157174S2 or HigherNo
GPOR 73022

Item 1 - Oxymetazoline Hydrochloride 0.01% w/v Nasal Solution, 5ml bottle
Item 2 - Oxymetazoline Hydrochloride 0.025% w/v Nasal Solution, 10ml or 15ml bottle
Item 3 - Oxymetazoline Hydochloride 0.05% w/v Nasal Spray, 15ml bottle
GPOR 73022 20/01/202310/2/2023 12:00 PMhttp://discovery.ariba.com/rfx/15146535S4 or HigherNo
GPOR 72922
Item 1 - Sirolimus 0.5mg Tablets
Item 2 - Sirolimus 1mg Tablets
GPOR 7292220/01/202310/2/2023 12:00 PMhttp://discovery.ariba.com/rfx/15157755S3 or HigherNo
GPOR 72822

​Item 1 - Unregistered Drugs

GPOR 7282213/01/20233/2/2023 12:00 PMhttp://discovery.ariba.com/rfx/15098215S2 or HigherNo